This study investigates if Shinbaro capsule has a lower incident of gastrointestinal events than celecoxib in subjects with osteoarthritis.

Read more: http://www.clinicaltrials.gov/ct2/show/NCT01604239?cond=%22Arthritis%22&lup_s=10/31/2013&lup_d=30